Allianz Asset Management Portfolio holdings
AUM
$74.9B
This Quarter Return
-4.41%
1 Year Return
+18.5%
3 Year Return
+81.04%
5 Year Return
+172.66%
10 Year Return
+376.49%
AUM
$68B
AUM Growth
+$68B
(-1.5%)
Cap. Flow
+$1.55B
Cap. Flow
% of AUM
2.28%
Top 10 Holdings %
Top 10 Hldgs %
24.83%
Holding
1,881
New
189
Increased
706
Reduced
735
Closed
148
Top Buys
| 1 |
VG
Venture Global, Inc.
VG
|
$3.55B |
| 2 |
SPDR Portfolio S&P 500 ETF
SPLG
|
$235M |
| 3 |
Morgan Stanley
MS
|
$158M |
| 4 |
Altria Group
MO
|
$155M |
| 5 |
PMBS
PIMCO Mortgage-Backed Securities Active Exchange-Traded Fund
PMBS
|
$141M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
$612M |
| 2 |
Apple
AAPL
|
$422M |
| 3 |
Amazon
AMZN
|
$320M |
| 4 |
Visa
V
|
$154M |
| 5 |
UnitedHealth
UNH
|
$148M |
Sector Composition
| 1 | Technology | 25.49% |
| 2 | Healthcare | 12.11% |
| 3 | Financials | 10.77% |
| 4 | Consumer Discretionary | 8.78% |
| 5 | Energy | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1676
MiMedx Group
MDXG
$1.05B
| $128K | ﹤0.01% |
+16,900
| New | +$128K |
|
1677
Definitive Healthcare
DH
$405M
| $121K | ﹤0.01% |
42,000
+17,300
| +70% | +$50K |
|
|
VRN
1678
DELISTED
Veren
VRN
| $117K | ﹤0.01% |
17,746
+1,448
| +9% | +$9.58K |
|
1679
Fastly
FSLY
$1.08B
| $111K | ﹤0.01% |
+17,500
| New | +$111K |
|
1680
NerdWallet
NRDS
$771M
| $108K | ﹤0.01% |
11,900
| – | – |
|
1681
BioCryst Pharmaceuticals
BCRX
$1.74B
| $103K | ﹤0.01% |
13,700
+1,200
| +10% | +$9K |
|
1682
Garrett Motion
GTX
$2.61B
| $102K | ﹤0.01% |
12,200
-100
| -0.8% | -$837 |
|
1683
Grab
GRAB
$20.1B
| $102K | ﹤0.01% |
22,510
+484
| +2% | +$2.19K |
|
1684
Solid Biosciences
SLDB
$448M
| $100K | ﹤0.01% |
+27,100
| New | +$100K |
|
1685
Compass
COMP
$4.76B
| $99.2K | ﹤0.01% |
11,368
-12,499
| -52% | -$109K |
|
1686
Adaptive Biotechnologies
ADPT
$1.96B
| $95.1K | ﹤0.01% |
12,800
+100
| +0.8% | +$743 |
|
1687
89bio
ETNB
$1.37B
| $93.1K | ﹤0.01% |
+12,800
| New | +$93.1K |
|
1688
WisdomTree
WT
$1.99B
| $91.9K | ﹤0.01% |
10,300
| – | – |
|
1689
Alto Neuroscience
ANRO
$97.7M
| $79.9K | ﹤0.01% |
37,000
-25,100
| -40% | -$54.2K |
|
1690
Olo Inc
OLO
$1.74B
| $77.3K | ﹤0.01% |
12,800
| – | – |
|
1691
IAMGOLD
IAG
$5.47B
| $69.4K | ﹤0.01% |
11,126
-58,031
| -84% | -$362K |
|
1692
Iovance Biotherapeutics
IOVA
$800M
| $67.6K | ﹤0.01% |
+20,300
| New | +$67.6K |
|
1693
AbCellera Biologics
ABCL
$1.19B
| $60.5K | ﹤0.01% |
25,622
+14,044
| +121% | +$33.1K |
|
1694
Ribbon Communications
RBBN
$710M
| $56.8K | ﹤0.01% |
+14,500
| New | +$56.8K |
|
1695
MarketWise
MKTW
$48.6M
| $51.8K | ﹤0.01% |
7,500
| – | – |
|
1696
Montauk Renewables
MNTK
$300M
| $36.4K | ﹤0.01% |
17,400
+6,600
| +61% | +$13.8K |
|
1697
PIMCO Active Bond Exchange-Traded Fund
BOND
$5.79B
| $32.2K | ﹤0.01% |
348
+6
| +2% | +$555 |
|
1698
Liberty Media Series C
FWONK
$25B
| $28.3K | ﹤0.01% |
+314
| New | +$28.3K |
|
1699
iQIYI
IQ
$2.61B
| $28.2K | ﹤0.01% |
12,465
| – | – |
|
1700
Central Garden & Pet Class A
CENTA
$2.11B
| $21.3K | ﹤0.01% |
652
-1,846
| -74% | -$60.4K |
|